First Time Loading...

MorphoSys AG
XETRA:MOR

Watchlist Manager
MorphoSys AG Logo
MorphoSys AG
XETRA:MOR
Watchlist
Price: 68.1 EUR -1.8%
Updated: May 21, 2024

MorphoSys AG
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

MorphoSys AG
Operating Expenses Peer Comparison

Comparables:
BNTX
CVAC
IMTX
BIO
FYB

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
MorphoSys AG
XETRA:MOR
Operating Expenses
-€611.1m
CAGR 3-Years
-25%
CAGR 5-Years
-37%
CAGR 10-Years
-25%
BioNTech SE
NASDAQ:BNTX
Operating Expenses
-€2.3B
CAGR 3-Years
-66%
CAGR 5-Years
-69%
CAGR 10-Years
N/A
CureVac NV
NASDAQ:CVAC
Operating Expenses
-€207.2m
CAGR 3-Years
-13%
CAGR 5-Years
-25%
CAGR 10-Years
N/A
Immatics NV
NASDAQ:IMTX
Operating Expenses
-€155.7m
CAGR 3-Years
-16%
CAGR 5-Years
-32%
CAGR 10-Years
N/A
Biotest AG
XETRA:BIO
Operating Expenses
-€174.6m
CAGR 3-Years
-9%
CAGR 5-Years
-8%
CAGR 10-Years
-1%
Formycon AG
XETRA:FYB
Operating Expenses
-€23.3m
CAGR 3-Years
-18%
CAGR 5-Years
-15%
CAGR 10-Years
N/A

See Also

What is MorphoSys AG's Operating Expenses?
Operating Expenses
-611.1m EUR

Based on the financial report for Mar 31, 2024, MorphoSys AG's Operating Expenses amounts to -611.1m EUR.

What is MorphoSys AG's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-25%

Over the last year, the Operating Expenses growth was -33%. The average annual Operating Expenses growth rates for MorphoSys AG have been -25% over the past three years , -37% over the past five years , and -25% over the past ten years .